Company will provide systems engineering supportto the Naval Information Warfare Center Pacific
Oppenheimer Downgrades NeuBase Therapeutics to Perform
Oppenheimer analyst Hartaj Singh downgrades NeuBase Therapeutics (NASDAQ:NBSE) from Outperform to Perform.